Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?
2014
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
2008 StandoutNobel
Cutting Edge: Langerin/CD207 Receptor on Dendritic Cells Mediates Efficient Antigen Presentation on MHC I and II Products In Vivo
2008 StandoutNobel
Computational flow cytometry: helping to make sense of high-dimensional immunology data
2016
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Dendritic Cells: Translating Innate to Adaptive Immunity
2006 StandoutNobel
Mis-translation of a Computationally Designed Protein Yields an Exceptionally Stable Homodimer: Implications for Protein Engineering and Evolution
2006 StandoutNobel
Therapeutic modulation of Notch signalling — are we there yet?
2014
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
2014
Precision therapy for lymphoma—current state and future directions
2014
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
The biology and function of fibroblasts in cancer
2016 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
A listing of human tumor antigens recognized by T cells
2001
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Cancer stem cells revisited
2017 Standout
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
2018
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Structural and mechanistic insights into hepatitis C viral translation initiation
2006 StandoutNobel
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Current trends in the treatment of primary mediastinal large B-cell lymphoma – an overview
2015
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Pushing the limits of the scanning mechanism for initiation of translation
2002
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Early lesions of follicular lymphoma: a genetic perspective
2013
Dimensionality reduction for visualizing single-cell data using UMAP
2018 Standout
Regulatory T cells in tumor immunity
2010 StandoutNobel
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Endosome maturation
2011 Standout
Immune targets and neoantigens for cancer immunotherapy and precision medicine
2016
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Dendritic cells: Understanding immunogenicity
2007 StandoutNobel
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Molecular pathogenesis of mantle cell lymphoma
2012
Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
2019
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma
2017
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Database of T cell-defined human tumor antigens: the 2013 update.
2013
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
2005 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
2015
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.
2002
Transformed follicular non-Hodgkin lymphoma
2014
Mass Spectrometry Analysis and Quantitation of Peptides Presented on the MHC II Molecules of Mouse Spleen Dendritic Cells
2011 StandoutNobel
Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes
2013 StandoutNobel
Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region
2004 StandoutNobel
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
2005
Works of Robert Kridel being referenced
Pathogenesis of follicular lymphoma
2012
Automated Analysis of Multidimensional Flow Cytometry Data Improves Diagnostic Accuracy Between Mantle Cell Lymphoma and Small Lymphocytic Lymphoma
2011
Genomic Rearrangements Involving Programmed Death Ligands Are Recurrent In Primary Mediastinal Large B-Cell Lymphoma
2013
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
2014
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
2011
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
2016
Prevention of CNS relapse in diffuse large B-cell lymphoma
2011
An Alternative Open Reading Frame of the Human Macrophage Colony-Stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-Infiltrating Cd8 T Lymphocytes
2001
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
2017